Equifax Inc.
EFX | NYSE
$191.29
+$6.69 (+3.62%)
Nov 2, 2026, 11:22 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Revenue | 6.07B | 5.68B | 5.27B | 5.12B | 4.92B | 4.13B |
Cost of Revenue | 2.65B | 2.52B | 2.34B | 2.18B | 1.98B | 1.74B |
Gross Profit | 3.43B | 3.16B | 2.93B | 2.95B | 2.94B | 2.39B |
Operating Income | 1.1B | 1.04B | 933.6M | 1.06B | 1.14B | 676.6M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 894.9M | 810.5M | 717.9M | 929.7M | 949.2M | 685.2M |
Net Income | 660.3M | 604.1M | 545.3M | 696.2M | 744.2M | 520.1M |
Selling & General & Admin | 1.61B | 1.45B | 1.39B | 1.33B | 1.32B | 1.32B |
Research & Development | n/a | n/a | n/a | n/a | n/a | n/a |
Other Expenses | 719.5M | 669.8M | 610.8M | 560.1M | 480.4M | 391M |
Operating Expenses | 2.33B | 2.12B | 2B | 1.89B | 1.81B | 1.71B |
Interest Expense | 212.3M | 229.1M | 241.4M | 183M | 145.6M | 141.6M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.98B | 4.64B | 4.33B | 4.07B | 3.79B | 3.45B |
Income Tax Expense | 230.6M | 203.2M | 166.2M | 229.5M | 200.7M | 159M |
Shares Outstanding (Basic) | 123.2M | 123.8M | 122.9M | 122.4M | 121.9M | 121.5M |
Shares Outstanding (Diluted) | 124.1M | 124.9M | 123.9M | 123.3M | 123.6M | 122.8M |
EPS (Basic) | 5.36 | 4.88 | 4.44 | 5.69 | 6.11 | 4.28 |
EPS (Diluted) | 5.32 | 4.84 | 4.40 | 5.65 | 6.02 | 4.24 |
EBITDA | 1.87B | 1.72B | 1.58B | 1.68B | 1.58B | 1.23B |
EBIT | 1.14B | 1.04B | 959.3M | 1.11B | 1.09B | 826.8M |
Depreciation & Amortization | 726.9M | 680.6M | 619.8M | 568.6M | 489.6M | 399.3M |
Add to Watchlist
Select watchlists to add or remove EFX